有无移植物功能延迟的肾移植受者的再入院结果。

IF 0.8 4区 医学 Q4 IMMUNOLOGY
{"title":"有无移植物功能延迟的肾移植受者的再入院结果。","authors":"","doi":"10.1016/j.transproceed.2024.08.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Delayed graft function (DGF) is a common post-transplant event associated with increased resource utilization. As a center with experience in DGF, we aimed to assess differences in readmissions and post-transplant outcomes between patients with and without DGF.</p></div><div><h3>Methods</h3><p>This was a retrospective review of deceased donor kidney transplant recipients at Mayo Clinic Arizona between 2015 and 2020. Recipients with at least one early readmission following kidney transplantation were included in the study. Two groups were identified: (1) recipients with DGF who required early readmission and (2) recipients without DGF who required early readmission.</p></div><div><h3>Results</h3><p>Among recipients with DGF, 43.9% (n = 405) required early readmission compared to 29.1% (n = 179) without DGF (<em>P</em> &lt; .0001). There were no differences in the initial hospital length of stay (<em>P</em> = .08), and most recipients in both groups only required a single readmission (61.7% vs 72.1%, <em>P</em> = .02). Recipients with DGF were more likely to have ≥2 readmissions (<em>P</em> = .02) and a higher total readmission rate (<em>P</em> = .006). Recipients with DGF who required readmission also required more outpatient clinic visits (<em>P</em> = .003). When comparing recipients with and without DGF who required readmission, there were no differences in patient (<em>P</em> = .22) or death-censored (<em>P</em> = .72) graft survival. When comparing patients with and without DGF requiring one versus ≥2 readmissions, there were no differences in patient survival (<em>P</em> = .15), however patients with DGF and ≥2 readmissions had lower death-censored graft survival (<em>P</em> = .001).</p></div><div><h3>Conclusions</h3><p>Recipients with DGF are at increased risk of readmission. Transplant center-level changes to reduce readmissions and infections could have an important impact on DGF outcomes.</p></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Readmission Outcomes in Kidney Transplant Recipients With and Without Delayed Graft Function\",\"authors\":\"\",\"doi\":\"10.1016/j.transproceed.2024.08.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Delayed graft function (DGF) is a common post-transplant event associated with increased resource utilization. As a center with experience in DGF, we aimed to assess differences in readmissions and post-transplant outcomes between patients with and without DGF.</p></div><div><h3>Methods</h3><p>This was a retrospective review of deceased donor kidney transplant recipients at Mayo Clinic Arizona between 2015 and 2020. Recipients with at least one early readmission following kidney transplantation were included in the study. Two groups were identified: (1) recipients with DGF who required early readmission and (2) recipients without DGF who required early readmission.</p></div><div><h3>Results</h3><p>Among recipients with DGF, 43.9% (n = 405) required early readmission compared to 29.1% (n = 179) without DGF (<em>P</em> &lt; .0001). There were no differences in the initial hospital length of stay (<em>P</em> = .08), and most recipients in both groups only required a single readmission (61.7% vs 72.1%, <em>P</em> = .02). Recipients with DGF were more likely to have ≥2 readmissions (<em>P</em> = .02) and a higher total readmission rate (<em>P</em> = .006). Recipients with DGF who required readmission also required more outpatient clinic visits (<em>P</em> = .003). When comparing recipients with and without DGF who required readmission, there were no differences in patient (<em>P</em> = .22) or death-censored (<em>P</em> = .72) graft survival. When comparing patients with and without DGF requiring one versus ≥2 readmissions, there were no differences in patient survival (<em>P</em> = .15), however patients with DGF and ≥2 readmissions had lower death-censored graft survival (<em>P</em> = .001).</p></div><div><h3>Conclusions</h3><p>Recipients with DGF are at increased risk of readmission. Transplant center-level changes to reduce readmissions and infections could have an important impact on DGF outcomes.</p></div>\",\"PeriodicalId\":23246,\"journal\":{\"name\":\"Transplantation proceedings\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transplantation proceedings\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0041134524004147\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041134524004147","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:移植物功能延迟(DGF)是一种常见的移植后事件,与资源利用率增加有关。作为一家在 DGF 方面经验丰富的中心,我们旨在评估有 DGF 和无 DGF 患者之间再入院率和移植后预后的差异:这是一项对亚利桑那州梅奥诊所 2015 年至 2020 年间已故供体肾移植受者的回顾性研究。研究纳入了肾移植后至少有一次早期再入院的受者。研究确定了两组受者:(1) 需要提前再入院的 DGF 受者;(2) 不需要提前再入院的 DGF 受者:结果:在患有 DGF 的受者中,43.9%(n = 405)需要提前再入院,而没有 DGF 的受者为 29.1%(n = 179)(P < .0001)。最初的住院时间没有差异(P = .08),两组中的大多数受试者只需再次入院一次(61.7% vs 72.1%,P = .02)。DGF受者再入院次数≥2次的可能性更大(P = .02),总再入院率更高(P = .006)。需要再次入院的 DGF 受者也需要更多的门诊就诊次数(P = .003)。在比较需要再入院的 DGF 受者和不需要再入院的 DGF 受者时,患者(P = .22)或死亡剪除(P = .72)移植物存活率没有差异。如果比较有DGF和没有DGF但需要一次和≥两次再入院的患者,患者存活率没有差异(P = .15),但有DGF且≥两次再入院的患者的死亡校正移植物存活率较低(P = .001):结论:DGF受者再入院风险增加。移植中心为减少再入院和感染而做出的改变可能会对DGF的预后产生重要影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Readmission Outcomes in Kidney Transplant Recipients With and Without Delayed Graft Function

Background

Delayed graft function (DGF) is a common post-transplant event associated with increased resource utilization. As a center with experience in DGF, we aimed to assess differences in readmissions and post-transplant outcomes between patients with and without DGF.

Methods

This was a retrospective review of deceased donor kidney transplant recipients at Mayo Clinic Arizona between 2015 and 2020. Recipients with at least one early readmission following kidney transplantation were included in the study. Two groups were identified: (1) recipients with DGF who required early readmission and (2) recipients without DGF who required early readmission.

Results

Among recipients with DGF, 43.9% (n = 405) required early readmission compared to 29.1% (n = 179) without DGF (P < .0001). There were no differences in the initial hospital length of stay (P = .08), and most recipients in both groups only required a single readmission (61.7% vs 72.1%, P = .02). Recipients with DGF were more likely to have ≥2 readmissions (P = .02) and a higher total readmission rate (P = .006). Recipients with DGF who required readmission also required more outpatient clinic visits (P = .003). When comparing recipients with and without DGF who required readmission, there were no differences in patient (P = .22) or death-censored (P = .72) graft survival. When comparing patients with and without DGF requiring one versus ≥2 readmissions, there were no differences in patient survival (P = .15), however patients with DGF and ≥2 readmissions had lower death-censored graft survival (P = .001).

Conclusions

Recipients with DGF are at increased risk of readmission. Transplant center-level changes to reduce readmissions and infections could have an important impact on DGF outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Transplantation proceedings
Transplantation proceedings 医学-免疫学
CiteScore
1.70
自引率
0.00%
发文量
502
审稿时长
60 days
期刊介绍: Transplantation Proceedings publishes several different categories of manuscripts, all of which undergo extensive peer review by recognized authorities in the field prior to their acceptance for publication. The first type of manuscripts consists of sets of papers providing an in-depth expression of the current state of the art in various rapidly developing components of world transplantation biology and medicine. These manuscripts emanate from congresses of the affiliated transplantation societies, from Symposia sponsored by the Societies, as well as special Conferences and Workshops covering related topics. Transplantation Proceedings also publishes several special sections including publication of Clinical Transplantation Proceedings, being rapid original contributions of preclinical and clinical experiences. These manuscripts undergo review by members of the Editorial Board. Original basic or clinical science articles, clinical trials and case studies can be submitted to the journal?s open access companion title Transplantation Reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信